SANOFI GENZYME
Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a le... ader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.
SANOFI GENZYME
Industry:
Biotechnology Therapeutics
Founded:
1981-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.sanofigenzyme.com
Total Employee:
5001+
Status:
Active
Technology used in webpage:
SPF Domain Not Resolving Amazon AJAX Libraries API BootstrapCDN Facebook Sharer IIS 8 ASP.NET MVC Elastic Email
Current Employees Featured
Founder
Newest Events participated
Participated in 3rd World Congress on Thyroid Cancer
on 2017-07-27 as exhibitor
Participated in 3rd World Congress on Thyroid Cancer
on 2017-07-27 as sponsor
Official Site Inspections
http://www.sanofigenzyme.com
- Host name: ec2-54-247-151-159.eu-west-1.compute.amazonaws.com
- IP address: 54.247.151.159
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Sanofi Genzyme"
Sanofi Genzyme - Crunchbase Company Profile
Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help …See details»
Genzyme - Wikipedia
Genzyme (also known as Genzyme Transgenics Corp or GTC Biotherapeutics) was an American biotechnology company based in Cambridge, Massachusetts. From its acquisition in 2011 to 2022 Genzyme operated as a fully owned subsidiary of Sanofi. In 2010, Genzyme was the world's third-largest biotechnology company, employing more than 11,000 people around the worl…See details»
Sanofi Genzyme - Craft
Sep 22, 2021 Sanofi Genzyme €10.43 b in annual revenue in FY 2019. See insights on Sanofi Genzyme including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Genzyme Corporation - Dun & Bradstreet
Company Description: Sanofi Genzyme (formerly Genzyme) makes it way battling uncommon diseases. The company's product portfolio ,focuses on treatments for multiple sclerosis, rare …See details»
Sanofi Genzyme - PitchBook
Sanofi Genzyme General Information Description. Manufacturer of human healthcare products intended to serve the markets in Cambridge, Massachusetts. The company focuses on rare …See details»
Sanofi Genzyme - Devex
Learn more about Sanofi Genzyme's jobs, projects, latest news, contact information and geographical presence. As the specialty care global business unit of Sanofi, they are focused …See details»
Sanofi Genzyme - Company Profile & Staff Directory - ContactOut
Sanofi Genzyme is a Biotechnology company located in 50 Binney St, Cambridge, Massachusetts 02142, US with 9,973 employees. Access Sanofi Genzyme's email format and Sanofi …See details»
Sanofi Genzyme Canada - PharmaBoardroom
Sep 10, 2017 Sanofi Genzyme EVP Bill Sibold Reflects on 30 Years of Rare Disease CSR Program. Bill Sibold, Executive Vice President and Head of Sanofi Genzyme, highlights the …See details»
Genzyme, a sanofi company Information - RocketReach
Genzyme is committed to discovering and delivering transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before.See details»
Sanofi Genzyme - Employees, Contact info, Overview - Wiza
May 1, 2024 View info about Sanofi Genzyme (sanofigenzyme.com). Sanofi Genzyme is a company located in Cambridge, Massachusetts, United States. Find employees, official …See details»
Sanofi Genzyme - Products, Competitors, Financials, Employees ...
Jan 23, 2025 sanofigenzyme.com. Overview & Products; People; About Sanofi Genzyme. Sanofi Genzyme is the specialty care business unit of Sanofi, focusing on the development and …See details»
Sanofi Genzyme CEO and Key Executive Team | Craft.co
Sanofi Genzyme's Executive Vice President and Head of Sanofi is Bill Sibold. Other executives include Paul Hudson, Chief Executive Officer; Serge Weinberg, Chairman of the Board of …See details»
Genzyme Europe B.V. - Devex
Learn more about Genzyme Europe B.V.'s jobs, projects, latest news, contact information and geographical presence. Genzyme is committed to discovering and delivering transformative …See details»
Sanofi-Aventis to buy Genzyme in search for new sales
Feb 16, 2011 French pharmaceutical group Sanofi-Aventis has agreed to buy US biotech company Genzyme for $20.1bn (14.8bn euros; £12.4bn). The acquisition of Genzyme will give …See details»
Sanofi Genzyme | Company Overview & News - Forbes
KSQ Therapeutics, a Cambridge, Mass.-based biotechnology that uses the genetic-engineering tool CRISPR to develop new drugs, has raised $80 million, it's second big raise in as many years.See details»
Sanofi-Genzyme: Still successful 5 years after the acquisition
In 2016, Sanofi also launched a huge makeover of its internal organization. The business will now be divided into five units: General medicines & Emerging markets, Specialty Care, Diabetes & …See details»
Sanofi moves deeper into Genzyme operations | Fierce Pharma
Jun 15, 2011 "[Y]ou can never answer that question fast enough," Viehbacher said. "Our commitment is to try to come to these integration decisions at a 10,000-person organization …See details»
Timeline: Sanofi's quest for U.S. biotech Genzyme | Reuters
Sanofi-Aventis has reached an agreement in principle to acquire Genzyme Corp for about $19.2 billion in cash plus future payments based on the performance of an experimental Genzyme …See details»
Eleven years after buying Genzyme, Sanofi officially ditches ... - STAT
Feb 3, 2022 Sanofi is also dropping the second name of its international vaccines division, Sanofi Pasteur, which had been part of another company that merged with Sanofi in 2004.See details»
Sanofi Genzyme Company Overview, Contact Details
Feb 2, 2022 Recent Acquisition Sanofi's acquisition of Sanofi Genzyme for $20.1B presents a prime sales opportunity to leverage the expanded resources and market access of the parent …See details»